No homozygous deletion of SMN2 has been identified in SMA patients, supporting the hypothesis that the complete loss of SMN1 and SMN2 would result in embryonic or fetal lethality [6]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.